When drug manufacturers cause severe pharmaceutical injuries like gastroparesis, they should be held accountable and financially responsible for failing to test their drugs properly
Document daily doses and injection sites to ensure consistency and track progress
Topical GHK-Cu alone is unlikely to produce sufficient results
In clinical trials of GLP-1 medications, adults lost a mean of roughly 15% of body weight over about a year (STEP-1, Novo Nordisk
Semaglutide warnings and precautions While semaglutide is generally considered safe, there are some people who should not take semaglutide, including those who have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Hou A, Quan G, Yang B, Lu C, Chen M, Yang D, Wang L, Liu H, Pan X, Wu C